Abstract
Background: Continuous renal replacement therapy (CRRT) may benefit patients requiring extracorporeal membrane oxygenation (ECMO). However, the clinical benefits and timing of CRRT have not been fully elucidated for these patients. Methods: This study was conducted retrospectively at the Taipei Medical University Hospital between January 2008 and December 2010. We included patients who had Acute Kidney Injury Network (AKIN) stage 3 disease at the initiation of ECMO and subsequently underwent CRRT. We excluded patients aged 2. Conclusion: No survival benefit is conferred by the use of CRRT within 24 h after initiating ECMO in patients with severe acute kidney injury according to AKIN criteria.
| Original language | English |
|---|---|
| Pages (from-to) | 130-139 |
| Number of pages | 10 |
| Journal | CardioRenal Medicine |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Aug 2014 |
Keywords
- Acute kidney injury
- Continuous renal replacement therapy
- Extracorporeal membrane oxygenation
- Glomerular filtration rate
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Urology